The right gastroepiploic artery in coronary artery bypass grafting.
The right gastroepiploic artery (RGEA) has been used as a conduit in coronary artery bypass grafting. Although some reports presenting good results justify its use in clinical settings, there is still much concern about using the RGEA in bypass surgery. The RGEA demonstrates different behaviors from the internal thoracic artery (ITA) in bypass surgery due to its histological characteristics and anatomical difference, which might contribute to the long-term outcome. Now that left ITA (LITA) to left anterior descending artery (LAD) is the gold standard, other grafts are expected to cover the rest of the coronary arteries. It should be elucidated how we can use other grafts and what we can expect from them. RGEA, as an arterial graft, can be used as an in situ graft or a free graft. The RGEA is mainly used to graft to the right coronary artery (RCA) because of its anatomical position, and its patency is not inferior to that of the saphenous vein (SVG). The RGEA can cover the lateral walls when its length is long enough or by making a composite graft with other grafts. However, when used to graft to the LAD, its mid-term patency is not favorable.
Sasaki
Hideki
H
Department of Cardiothoracic Surgery, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA. baggio199869@gmail.com
D000075202:Contraindications; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods*; D024405:Gastroepiploic Artery / Q000637:transplantation*; D006801:Humans; D020858:Tissue and Organ Harvesting; D014654:Vascular Patency